CCL17 and primary cutaneous T-cell non-Hodgkin lymphoma: The pathogenic role of CCL17/TARC was suggested in skin diseases such as AD, cutaneous T-cell lymphoma, bullous pemphigoid, scabies and drug eruption [28,29,30].